NCT Number: NCT02656927
Evaluation of a Specialized Yoga Program for Persons With Spinal Cord Injury (SCI)
The purpose of this randomized controlled study is to evaluate psychological variables, mindfulness, and pain in the context of a specialized yoga program for individuals with SCI. Participants will be randomized to either a wait-list control condition or to a specialized yoga program condition.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- have an SCI or a spinal related condition,
- be 18 years of age or older,
- be able to speak and read English,
- commit to two weekly, one hour yoga classes for six weeks,
- be referred from a clinician on the inter-disciplinary team,
- have a sitting tolerance of one hour,
- be able to participate in gentle physical activity in that time,
- be aware of and understand his/her health contraindications (is able to practice safely),
- provide a note from their physician indicating that it is safe for them to participate in a physical activity intervention, such as yoga.
Exclusion criteria
- are not medically stable,
- have pre-existing medical contraindications,
- have cognitive limitations or language comprehension issues that would impact participation (determined by care team),
- have had a regular yoga practice in the last six months.
Treatment and study plan
Primary outcomes
-
Acceptance and Action Questionnaire-II (AAQ-II)
Time frame: Change from Baseline, 6 weeks, 12 weeks
Secondary outcomes
-
Hospital Anxiety and Depression Scale (HADS)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
General Self-Efficacy Scale (GSES)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
Post-Traumatic Growth Inventory-SF (PTGI-SF)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
Connor-Davidson Resilience Scale-10 Item (CS-RISC-10)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
Five Facet Mindfulness Questionnaire-SF (FFMQ-SF)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
Self-Compassion Scale-SF (SCS-SF)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
Brief Pain Inventory-SF (BPI-SF)
Time frame: Change from Baseline, 6 weeks, 12 weeks
-
Pain Catastrophizing Scale (PCS)
Time frame: Change from Baseline, 6 weeks, 12 weeks
Sponsors and collaborators
Lead sponsor
University Health Network, Toronto
Other
Registry information
Official study title
Evaluation of a Specialized Yoga Program for Persons With Spinal Cord Injury: A Randomized Controlled Trial
Acronym: SCI
Important dates
- Study start
- 2016
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jan 15, 2016
- Registry last updated
- Jul 28, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury
NCT01135108
Central Nervous System Diseases, Nervous System Diseases
Sydney, New South Wales, Australia
View Trial DetailsInvestigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
NCT00320281
Central Nervous System Diseases, Nervous System Diseases
Englewood, Colorado, United States
View Trial DetailsDeep rTMS in Central Neuropathic Pain Syndromes
NCT01932905
Central Nervous System Diseases, Chronic Pain
São Paulo, Brazil
View Trial DetailsBiomechanics of Wheelchair Transfers
NCT00645567
Central Nervous System Diseases, Nervous System Diseases
Tampa, Florida, United States
View Trial Details